About Orbis Biosciences
Orbis Biosciences is a company based in United States founded in 2008 was acquired by Adare Pharma Solutions in April 2020.. Orbis Biosciences has raised $677.06 thousand across 11 funding rounds from investors including HHS and Adare Pharma Solutions. Orbis Biosciences operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Kansas, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$677.06 K (USD)
in 11 rounds
-
Latest Funding Round
$224.96 K (USD), Grant
Jul 07, 2017
-
Investors
HHS
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Adare Pharma Solutions
(Apr 30, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Orbis Biosciences
Orbis Biosciences has successfully raised a total of $677.06K across 11 strategic funding rounds. The most recent funding activity was a Grant round of $224.96 thousand completed in July 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Grant — $224,963
-
First Round
First Round
(01 Nov 2008)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2017 | Amount | Grant - Orbis Biosciences | Valuation |
investors |
|
| Apr, 2017 | Amount | Debt – Conventional - Orbis Biosciences | Valuation |
investors |
|
| Sep, 2013 | Amount | Grant - Orbis Biosciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Orbis Biosciences
Orbis Biosciences has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Adare Pharma Solutions. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
CDMO manufacturing solid drugs
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Orbis Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Orbis Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Orbis Biosciences Comparisons
Competitors of Orbis Biosciences
Orbis Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Orbis Biosciences
Frequently Asked Questions about Orbis Biosciences
When was Orbis Biosciences founded?
Orbis Biosciences was founded in 2008.
Where is Orbis Biosciences located?
Orbis Biosciences is headquartered in United States. It is registered at Kansas, United States.
Is Orbis Biosciences a funded company?
Orbis Biosciences is a funded company, having raised a total of $677.06K across 11 funding rounds to date. The company's 1st funding round was a Grant of $1.7M, raised on Nov 01, 2008.
What does Orbis Biosciences do?
Orbis Biosciences was founded in 2008 in Kansas, United States, and focuses on controlled-release delivery systems for the pharmaceutical, consumer product, chemical, and food and beverage sectors. Precision Particle Fabrication technology is utilized to enable product creation involving small molecules, macromolecules, polymers, nucleic acids, proteins, chemotherapeutics, and biologics. A lead candidate, a controlled-release form of prednisone, is currently in phase I clinical trials.
Who are the top competitors of Orbis Biosciences?
Orbis Biosciences's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Who are Orbis Biosciences's investors?
Orbis Biosciences has 2 investors. Key investors include HHS, and Adare Pharma Solutions.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.